awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827986-3C8A98DF-1A99-4203-9B64-CEB6FC221363
Q26827986-3C8A98DF-1A99-4203-9B64-CEB6FC221363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827986-3C8A98DF-1A99-4203-9B64-CEB6FC221363
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases
P2860
Q26827986-3C8A98DF-1A99-4203-9B64-CEB6FC221363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827986-3C8A98DF-1A99-4203-9B64-CEB6FC221363
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be3dbb850970789a31f230457631b2b8ba7d1737
P2860
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.